|
1
|
Menon U, Gentry-Maharaj A and Jacobs I:
Ovarian cancer screening and mortality. JAMA. 306:1544–1545. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jelovac D and Armstrong DK: Recent
progress in the diagnosis and treatment of ovarian cancer. CA
Cancer J Clin. 61:183–203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fan WH, Du FJ, Liu XJ and Chen N:
Knockdown of FRAT1 inhibits hypoxia-induced
epithelial-to-mesenchymal transition via suppression of the
Wnt/β-catenin pathway in hepatocellular carcinoma cells. Oncol Rep.
36:2999–3004. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mo D, Yang D, Xiao X, Sun R, Huang L and
Xu J: miRNA-145 suppresses lung adenocarcinoma cell invasion and
migration by targeting N-cadherin. Biotechnol Lett. 1–710.
2017.PubMed/NCBI
|
|
6
|
Lim J and Thiery JP:
Epithelial-mesenchymal transitions: Insights from development.
Development. 139:3471–3486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ramis-Conde I, Chaplain MA, Anderson AR
and Drasdo D: Multi-scale modelling of cancer cell intravasation:
The role of cadherins in metastasis. Phys Biol. 6:0160082009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Roy F: Beyond E-cadherin: Roles of
other cadherin superfamily members in cancer. Nat Rev Cancer.
14:121–134. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Faleiro-Rodrigues C, Macedo-Pinto I,
Pereira D and Lopes CS: Prognostic value of E-cadherin
immunoexpression in patients with primary ovarian carcinomas. Ann
Oncol. 15:1535–1542. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L
and Yin R: CCAT2 is a lung adenocarcinoma -specific long non-coding
RNA and promotes invasion of non-small cell lung cancer. Tumour
Biol. 35:5375–5380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Redis RS, Sieuwerts AM, Look MP, Tudoran
O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, et al:
CCAT2, a novel long non-coding RNA in breast cancer: Expression
study and clinical correlations. Oncotarget. 4:1748–1762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Crea F, Clermont PL, Parolia A, Wang Y and
Helgason CD: The non-coding transcriptome as a dynamic regulator of
cancer metastasis. Cancer Metastasis Rev. 33:1–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Richards EJ, Permuth-Wey J, Li Y, Chen YA,
Coppola D, Reid BM, Lin HY, Teer JK, Berchuck A, Birrer MJ, et al:
A functional variant in HOXA11-AS, a novel long non-coding RNA,
inhibits the oncogenic phenotype of epithelial ovarian cancer.
Oncotarget. 6:34745–34757. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW,
Jin HY, Zhang Y, Li Q and Hua KQ: Overexpression of long non-coding
RNA HOTAIR predicts poor patient prognosis and promotes tumor
metastasis in epithelial ovarian cancer. Gynecol Oncol.
134:121–128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Redis RS, Vela LE, Lu W, Ferreira de
Oliveira J, Ivan C, Rodriguez-Aguayo C, Adamoski D, Pasculli B,
Taguchi A, Chen Y, et al: Allele-specific reprogramming of cancer
metabolism by the long non-coding RNA CCAT2. Mol Cell. 61:520–534.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nieman KM, Kenny HA, Penicka CV, Ladanyi
A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB,
Hotamisligil GS, et al: Adipocytes promote ovarian cancer
metastasis and provide energy for rapid tumor growth. Nat Med.
17:1498–1503. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anderson AS, Roberts PC, Frisard MI,
Hulver MW and Schmelz EM: Ovarian tumor-initiating cells display a
flexible metabolism. Exp Cell Res. 328:44–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang YJ, Liu JZ, Lv P, Dang Y, Gao JY and
Wang Y: Long non-coding RNA CCAT2 promotes gastric cancer
proliferation and invasion by regulating the E-cadherin and LATS2.
Am J Cancer Res. 6:2651–2660. 2016.PubMed/NCBI
|
|
20
|
Huang S, Qing C, Huang Z and Zhu Y: The
long non-coding RNA CCAT2 is up-regulated in ovarian cancer and
associated with poor prognosis. Diagn Pathol. 11:492016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sawada K, Mitra AK, Radjabi AR, Bhaskar V,
Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A,
Kenny HA, et al: Loss of E-cadherin promotes ovarian cancer
metastasis via alpha 5-integrin, which is a therapeutic target.
Cancer Res. 68:2329–2339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Poser I, Domı́nguez D, Herreros AG, Varnai
A, Buettner R and Bosserhoff AK: Loss of E-cadherin expression in
melanoma cells involves up-regulation of the transcriptional
repressor Snail. J Biol Chem. 276:24661–24666. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arend RC, Londono-Joshi AI, Straughn Jr JM
and Buchsbaum DJ: The Wnt/β-catenin pathway in ovarian cancer: A
review. Gynecol Oncol. 131:772–779. 2001. View Article : Google Scholar
|
|
27
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gonzalez DM and Medici D: Signaling
mechanisms of the epithelial-mesenchymal transition. Sci Signal.
7:re82014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ford CE, Jary E, Ma SS, Nixdorf S,
Heinzelmann-Schwarz VA and Ward RL: The Wnt gatekeeper SFRP4
modulates EMT, cell migration and downstream Wnt signaling in
serous ovarian cancer cells. PLoS One. 8:e543622013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hua G, Hu G, Yang Q, Zhang P, Kuang W, Zhu
X and Wu L: Knockdown of long non-coding RNA CCAT2 suppressed
proliferation and migration of glioma cells. Oncotarget.
7:81806–81814. 2016.PubMed/NCBI
|
|
31
|
Cai Y, He J and Zhang D: Long noncoding
RNA CCAT2 promotes breast tumor growth by regulating the Wnt
signaling pathway. Onco Targets Ther. 8:2657–2664. 2015.PubMed/NCBI
|
